June 19th, 2009: Aurgalys – CLS  initiates analyst coverage of BioAlliance Pharma [Euronext: BIO]

BioAlliance Pharma is a biopharmaceutical company which develops and markets innovative therapeutics addressing unmet medical needs in the treatment and supportive care of life threatening diseases including cancer and AIDS

Download our BioAlliance Coverage here (available in english only)

www.bioalliancepharma.com

January 6th, 2009, Aurgalys and Cukierman & Co Life Sciences sign a business affiliate agreement to offer global solutions to the life science industry in Europe, North America and Israel

Given the current global financial crisis and new market needs, the partners’ core service offering focuses on M&A activity and strategic alliances

Download our English Press Release here

Téléchargez notre communiqué de presse, en français en cliquant ici